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Glucocorticoids play an important role in the treatment of
inflammation and immune disorders, despite side effects, which
include metabolic derangements such as central adiposity. These
studies examine the role of protein phosphatase 5 (Ppp5) in
glucocorticoid receptor (GR) complexes which mediate response
to glucocorticoids. Mice homozygous for inactivated Ppp5
(Ppp5D274A/D274A) exhibit decreased adipose tissue surrounding the
gonads and kidneys compared with wild-type mice. Adipocyte
size is smaller, more preadipocytes/stromal cell are present in
their gonadal fat tissue and differentiation of preadipocytes to
adipocytes is retarded. Glucocorticoid levels are raised and the
GR is hyperphosphorylated in adipose tissue of Ppp5D274A/D274A
mice at Ser212 and Ser220 (orthologous to human Ser203 and
Ser211) in the absence of glucocorticoids. Preadipocyte cultures
from Ppp5D274A/D274A mice show decreased down regulation of
Delta-like protein-1/preadipocyte factor-1, hyperphosphorylation
of extra-cellular signal regulated kinase 2 (ERK2) and increased
concentration of (sex determining region Y)-box 9 (SOX9),
changes in a pathway essential for preadipocyte differentiation,
which leads to decreased concentrations of the transcription
factors CEBPβ and CEBPα necessary for the later stages
of adipogenesis. The data indicate that Ppp5 plays a crucial
role in modifying GR-mediated initiation of adipose tissue
differentiation, suggesting that inhibition of Ppp5 may potentially
be beneficial to prevent obesity during glucocorticoid treatment.
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INTRODUCTION
Glucocorticoids are widely used as drugs to control both acute and
chronic inflammation and, at supraphysiological concentrations,
they display strong immunosuppressive actions. Their use,
however, is limited by side effects, which include metabolic
derangements such as central obesity, glucose intolerance and
insulin resistance, which are major risk factors for Type 2 diabetes
and cardiovascular disease. Glucocorticoids exert their effect
by binding to the glucocorticoid receptor (GR), a transcription
factor which, on ligand binding, translocates from the cytoplasm
to the nucleus, where it binds to specific sites in DNA and
modulates the expression of many genes. The GR interacts with
the chaperone heat shock protein (Hsp)90, which is involved in
assembly and maturation of the GR and other steroid receptors
[1]. Protein phosphatase 5 (Ppp5/PP5), which dephosphorylates
serine and threonine residues in proteins [2,3], was identified as a
component of GR-Hsp90 complexes [4,5] and shown to interact
with Hsp90 and Hsp70 via its tetratricopeptide repeat (TPR)
domain [6,7]. Three TPR-containing proteins, FK506 binding
protein 51 (FKBP51), FKBP52 and Ppp5/PP5 are now known to
separately associate with the mature GR through Hsp90, to form
different GR complexes [8,9]. A further small protein termed
p23 is an essential component of GR complexes [10]. Ppp5
is the only TPR protein that exhibits phosphatase activity in
the GR complexes, and interaction of Ppp5 TPR domain with
Hsp90 stimulates its protein phosphatase activity in vitro [11].
Ppp5 can also be activated in vitro by unsaturated and saturated
fatty acids [12–14]. Studies in cell cultures have suggested that
Ppp5 is a negative regulator of GR-mediated growth arrest [15]
and that Ppp5 may modify the transcriptional profile of the cell
[16]. However, analyses of two mouse models [17,18] where
the expression of Ppp5/PP5 protein was below detection, termed
PP5 ‘knockout’ (KO) (PP5KO), did not report any overt in
vivo physiological abnormalities attributed to alteration of GR
function. In the present study, we analyse a murine model, in
which an inactive Ppp5 replaces the wild-type Ppp5 and leads to
changes in GR-mediated fat deposition. The studies demonstrate
a major role of Ppp5 in preadipocyte differentiation.
MATERIALS AND METHODS
Generation and maintenance of Ppp5D274 A/+ and Ppp5D274A/D274A
mice
All animal procedures were approved by the University of Dundee
Ethical Committee and were performed under a UK Home
Office Project Licence. Mice expressing the required Asp274Ala
mutant Ppp5 were generated by ARTEMIS Pharmaceuticals. The
targeting vector employed, encompassed exons 4–12 of the Ppp5
gene with a GAC→GCT codon change in exon 7 specifying the
Asp274Ala substitution (Figure 1A). Neomycin (Neo) was used
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for positive selection and thymidine kinase (TK) for negative
selection. Upon homologous recombination, exons 4–12 of the
endogenous Ppp5 gene (PPP5 C) were replaced with DNA
encoding exons 4–6, exon 7 (with the GCT codon) and exons
8–12. C57BL/6 J genomic DNA was used for construction of
the targeting vector, which was introduced into C57BL/6 N
embryonic stem (ES) cells by electroporation. After selection
in G418-containing medium, resistant clones were screened by
PCR and Southern blotting, and cells from validated clones were
injected into blastocytes, which were then transferred to the uteri
of pseudopregnant foster mothers. Chimaeric male offspring were
mated with female Flpe mice (animals coisogenic with C57BL/6
and containing a random integration of a CAGGS promoter-
Flpe transgene, encoding a ubiquitous Flpe recombinase activity),
allowing parallel in vivo Neo selection marker deletion and germ
line transmission of the mutant GAC codon to the F1 offspring.
Two mouse lines originating from different ES cell clones carrying
the Ppp5D274 A allele were maintained by backcrossing.
Preparation and culture of preadipocytes
Primary preadipocyte isolation and culture was modified from
the method of [19]. Briefly, male or female mouse gonadal fat
pads were excised in sterile conditions and approximately 0.5 mg
placed in a 5 ml vial containing 1 ml of buffer comprising
Krebs-Ringer buffer and HEPES [140 mM NaCl, 4.7 mM KCl,
2.5 mM CaCl2, 1.25 mM MgCl2, 2.5 mM NaH2PO4, 25 mM
HEPES] with the addition of 3.5% BSA (w/v), 2 mM glucose,
200 mM adenosine riboside (Fluka, Sigma–Aldrich) and 1 mg/ml
collagenase type II (Worthington Biochemical Corp.) at room
temperature. The adipose tissue was finely minced using scissors
and incubated with the collagenase for 60 min at 37◦C in a
shaking water bath until fragments were no longer visible and
the digest had a milky white appearance. Digests were filtered
(BD Falcon cell strainer 70 μm) and centrifuged at 800 g for 10
min. The upper phase (floating adipocytes) was separated from
lower phase. The lower phase was treated with red blood cell
lysis buffer (Miltenyi Biotec) and centrifuged at 1000 g for 5
min. The upper phase was removed and the pellet containing
stromal cells and preadipocytes was resuspended in RPMI-1640
medium (Life Technologies, Inc.) supplemented with 10% FBS
or 10% dialysed FBS with molecules below 10 kDa removed
(Biosera), 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM
L-glutamine, 1% non-essential amino acids (Life Technologies,
Inc.), 1% sodium pyruvate and 10 ng/ml mouse granulocyte-
macrophage colony-stimulating factor (R&D Systems). The cells
were plated at a density 1 × 106 in a 10 cm diameter dish, cultured
until confluence was reached (2–4 days), then the medium was
changed, with FBS being lowered to 5%, and the cells were
cultured for a further 8–10 days in a humidified atmosphere with
5%CO2, 95% air at 37◦C. Preadipocytes were lysed as described
for mouse embryonic fibroblasts (MEFs).
Statistical analysis
Where appropriate, data are presented +− the S.E.M. Statistical
significance of the difference between the means of two data sets
was assessed using Student’s two tailed t-test unless otherwise
stated.
RESULTS
Genetic and phenotypic analysis of Ppp5+ /+ , Ppp5D274 A/+ and
Ppp5D274A/D274A mice
Mutation of Asp274 to Ala in Ppp5 would be predicted to lead
to inactivation because this amino acid is invariant throughout
the PPP family phosphatases and forms a salt bridge with
His304, which is required for donation of a hydrogen ion
during cleavage of phosphate from the substrate [20]. GST-
Ppp5 and GST-Ppp5(D274 A) generated in Escherichia coli
showed similar expression levels and migration on SDS/PAGE
(Figure S1C). Assay, after affinity purification on glutathione-
Sepharose, indicated that the mutant Ppp5 was virtually inactive,
expressing <0.27% (+−0.12% S.D.) of the wild-type Ppp5
activity. Ppp5+ / + , Ppp5D274 A/ + and Ppp5D274A/D274A mice, generated
as described (Figure 1A, S1A and S1B), were viable, with no
obvious phenotypic abnormalities at birth. Immunoblots of Ppp5
showed a band of the predicted size at 58 kDa in liver lysates of
Ppp5+ / + and Ppp5D274A/D274A mice. A cleaved Ppp5 band migrating
at 50 kDa, believed to be a form involved in the activity and
turnover of Ppp5 [7], was noted in Ppp5+ / + mice but was absent
from the Ppp5D274A/D274A liver lysates (Figure S1D).
Genetic analyses of the offspring of heterozygous (Ppp5D274 A/ + )
matings revealed a statistically significant decrease in the number
of male Ppp5D274A/D274A mice born compared with the number
expected (Figure 1B). The distribution of Ppp5 genotypes for the
combined male and female offspring is significantly different from
the expected distribution and there is a trend towards a decrease
in the numbers of female Ppp5D274A/D274A mice (Figures S1E and
S1F). There was also a trend towards significance for a decrease in
the number of male and female Ppp5D274A/D274A embryos compared
with the expected number (Figure 1C). Overall, these data suggest
that Ppp5D274A/D274A mice expressing an inactive Ppp5 are selected
against during prenatal development.
The weight of Ppp5D274A/D274A male mice increased more slowly
than the weights of Ppp5+ / + and Ppp5D274 A/ + male mice after 11
weeks of age (Figure 1D). An initial analysis of the internal organs
of mice greater than 6 months old suggested that the gonadal
and omental adipose tissue mass of Ppp5D274A/D274A mice was less
than that of age- and gender-matched control animals. Dissection
and weighing confirmed these observations in both male and
female Ppp5D274A/D274A and Ppp5D274 A/ + mice (Figures 1E and S1G)
and raised the question of whether slower expansion of adipose
tissue may underlie or contribute to the differences in growth
curves.
Fat depots of adult Ppp5D274A/D274A mice are decreased compared
with those in wild-type mice
Central obesity is caused by an excess of abdominal (also termed
visceral) adipose tissue, which comprises several fat depots
including fat surrounding the kidneys, fat surrounding the gonads
and fat at the front of the abdomen (omental fat) as well as
between the organs in the abdomen (mesenteric fat). The kidneys
and the adipose tissue surrounding the kidneys and gonads were
examined by MRI. The volumes derived from the 3D MRI images
for these tissues were then converted into weight as described
in the Materials and methods section. Imaging of kidney and
its associated adipose tissue demonstrated that these fat depots
were significantly decreased in Ppp5D274A/D274A compared with
Ppp5D274 A/ + and Ppp5+ / + mice (Figures 2A–2C). The kidney fat
and the kidney fat/kidney weight ratios showed a trend towards
lower values in heterozygous Ppp5D274 A/ + mice compared with
Ppp5+ / + controls. Quantification of the kidney adipose depots by
MRI directly correlated with data from manual weighing of the
kidney fat pads (Figure 2D).
The images of the adipose tissue surrounding the gonads
quantified by MRI show that the fat mass was decreased in
Ppp5D274 A/ + mice compared with Ppp5+ / + controls and markedly
decreased in Ppp5D274A/D274A mice (Figure S2A). Although some
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Figure 1 Generation and genetically determined features of mice expressing an inactivated Ppp5
(A) Schematic representation of the generation of Ppp5D274 A mutant allele in C57 BL/6 J mice as described in the Materials and methods section. (B) Genotype distribution of male offspring of
Ppp5D274 A/ + heterozygous crosses. † The difference from the expected distribution is significant P < 0.01. (C) Genotype distribution of 13.5-day embryos of heterozygous crosses. (D) Growth curve
for male mice of heterozygous crosses on a control diet. Increase in weight gain is significantly lower for Ppp5D274A/D274A mice than Ppp5+ / + mice at all ages (∧P < 0.05, *P < 0.01,†P < 0.001)
and for Ppp5D274 A/ + mice compared with Ppp5+ / + mice at weeks 12–16 (P < 0.01), weeks 18, 22 and 32 (P < 0.05). Numbers of mice weighed in different weeks Ppp5+ / + (12–25), Ppp5D274 A/ +
(16–35), Ppp5D274A/D274A (12–27). (E) Weight of adipose tissue (fat) dissected from the gonadal and omental fat depots of 7–9-month-old male Ppp5+ / + , Ppp5D274 A/ + and Ppp5D274A/D274A mice fed
on a standard chow diet and compared with the liver weight. Statistically significant data: *** Ppp5D274A/D274A compared with Ppp5+ / + P < 0.002, * Ppp5D274A/D274A compared with Ppp5D274 A/ +
P < 0.05.
variation was observed, mostly in heterozygous mice, the data
from weighing the gonadal fat directly correlated with the
measurements generated by MRI, except in the case of a very large
mouse (Figure S2B). This was probably due to the fat depots being
partially squashed in the cradle holding the mouse in the MRI
apparatus. Quantification of the liver volumes by MRI could not be
achieved accurately, so the gonadal fat mass determined by MRI
was therefore calculated as a ratio to the total body weight. The
differences between the gonadal fat mass compared with the body
weight in Ppp5D274A/D274A mice and Ppp5D274 A/ + compared with
Ppp5+ / + controls were statistically significant (Figure 2E). The
age range of the mice over which this difference was examined
and observed was 31.5–81 weeks, and it was present in two
mouse lines originating from different ES cell clones carrying
the Ppp5D274 A allele.
Transverse sections of the abdomen showed that other white
fat depots (subcutaneous fat and omental fat) were smaller in
Ppp5D274A/D274A compared with Ppp5+ / + mice (Figure S2A, bottom
panel). However, our high-resolution MRI scanner produced
images with a field of view of approximately 4 cm, and thus
c© 2015 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
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Figure 2 In vivo quantification of the kidney fat pads in Ppp5D274A/D274A, Ppp5D274 A/+ and Ppp5+ /+ mice by MRI
(A) 2D frontal MR images (ventral view) of kidneys with 5 mm rulers (top row), and surface reconstructions of kidneys (black) and kidney fat pads (adipose tissue surrounding the kidney, white)
(lower row) from 3D rapid acquisition relaxation enhanced (RARE)-4 MRI datasets of 81-week-old male mice. (B) Kidney, kidney and gonadal fat pads weights; volumes were determined by MRI
and converted into grams. (C) Comparison of the kidney fat pad/kidney weight ratios in Ppp5+ / + , Ppp5D274 A/ + and Ppp5D274A/D274A mice. Statistically significant data using a one tailed t -test:
*Ppp5D274 A/D274 compared with Ppp5+ / + P < 0.05, †Ppp5D274 A/D274 compared with Ppp5D274 A/ + P < 0.05. (D) Correlation between the kidney fat weights determined in vivo by MRI and ex vivo by
manual weighing in 29 male mice; R2 = 0.96. (E) Comparison of the gonadal fat/body weight ratios determined by MRI or manual weighing in 22 Ppp5+ / + , 14 Ppp5D274 A/ + and 16 Ppp5D274A/D274A
male mice. Ages were matched for the different genotypes and ranged from 31.5 to 81 weeks. Statistically significant data: **Ppp5D274 A/D274 compared with Ppp5+ / + P < 0.002, *Ppp5D274 A/D274
compared with Ppp5D274 A/ + P < 0.05.
it was not possible to quantify the subcutaneous fat across the
whole of the mouse. Nevertheless, inspection of the 3D MRI
image data sets qualitatively suggests that the small size of fat
depots in Ppp5D274A/D274A was not restricted to the gonadal or
peri-renal fat.
Analysis of gonadal adipose tissue and preadipocyte
differentiation in cultures from the adipose tissue
Haematoxylin–eosin staining of sections of the gonadal adipose
tissue showed that in a small field of view of constant area
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Figure 3 Comparison of gonadal adipose tissue sections from Ppp5+ /+ , Ppp5D274 A/+ and Ppp5D274A/D274A mice
(A) Sections of gonadal adipose tissue fixed and stained with haematoxylin-eosin to visualize the adipocyte nuclei (dark blue, labelled N) and preadipocyte/stromal cell cytoplasm (labelled SC and
visualized as pink on the original images). The stain is excluded from the lipid droplets. Blood capillaries (C) are indicated. The sections were imaged at magnifications of 10×, 40× and 100×. (B)
Mean dimension of >70 adipocytes for each mouse genotype, determined by measuring the maximum dimension of adipocytes visible in a field of view. Error bars indicate the SEM and statistical
significance is ***P < 10− 13. Tissue sections from three mice of each genotype showed similar results (C) Adipocytes were counted in three fields of view of the same area for each mouse genotype
indicated. Error bars indicate the SEM and statistical significance is **P < 0.0005, ***P < 10− 8.
and magnification, the sizes of the adipocytes are significantly
smaller in Ppp5D274A/D274A than in Ppp5D274 A/ + mice and Ppp5+ / +
controls (Figures 3A and 3B). Therefore, the number of adipocytes
is higher in the Ppp5D274A/D274A field of view (Figure 3C) but
not in the entire gonadal fat pads because the weight of the
gonadal fat pads is lower in Ppp5D274A/D274A than in heterozygous
and control mice. Importantly, more stromal cells are visible at
the junctions between adipocytes in Ppp5D274A/D274A mice than in
heterozygous or control mice (Figure 3A, 100× magnification).
The observations suggest there may be a partial defect in the
generation of adipocytes and subsequent accumulation of lipids
in Ppp5D274A/D274A mice.
To investigate the biochemical changes in adipose tissue
of Ppp5 deficient mice, preadipocytes were prepared from
the adipose tissue surrounding the gonads by digestion with
collagenase. The fraction containing the stromal cells and
preadipocytes was cultured in fresh RPMI medium containing
10% complete FBS until confluence (2 days) and then replated
in fresh medium containing 5% complete FBS and cultured
for a further 8 days. Ppp5+ / + cultures contained significantly
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more differentiated adipocytes compared with Ppp5D274A/D274A
and Ppp5D274 A/ + cultures (P < 0.01) as judged by staining
with Nile Red, which detects intracellular lipid droplets
(Figures 4A and 4B). When the stromal cell/preadipocyte
fraction was plated similarly but cultured in RPMI medium
containing dialysed FBS (to remove glucocorticoids and other
molecules below 10 kDa), the cells were slower to reach
confluence (4 days) and the differences in differentiation between
Ppp5+ / + controls and Ppp5D274 A/ + and Ppp5D274A/D274A cells
was more pronounced (P < 0.005) (Figure 4C). In RPMI
medium/dialysed FBS, there was a 10-fold difference in the
number of Ppp5+ / + and Ppp5D274A/D274A differentiated adipocytes,
whereas in RPMI/complete FBS the difference was only 2-
fold (compare Figures 4B and 4C). Overall, the data show that
Ppp5D274A/D274A and Ppp5D274 A/ + preadipocytes differentiate more
slowly than preadipocytes from Ppp5+ / + controls, particularly in
media depleted of glucocorticoids.
Whole body biochemical analyses of Ppp5D274A/D274A and
Ppp5D274 A/+ mice
There was no significant difference between the fasting
blood glucose levels of Ppp5D274A/D274A and Ppp5D274 A/ + and
Ppp5+ / + mice, but following an intraperitoneal injection of a
bolus of glucose, Ppp5D274A/D274A and Ppp5D274 A/ + mice exhibited
a slightly but significantly more rapid clearance of glucose from
the blood when compared with Ppp5+ / + controls (Figure 4D).
The clearance of glucose from the blood after an intraperitoneal
injection of a bolus of insulin was also slightly more rapid in
Ppp5D274A/D274A and Ppp5D274 A/ + mice than in Ppp5+ / + controls
(Figure S3A).
In order to examine whether inhibition of Ppp5 might be a useful
pharmaceutical target for management of diet-induced obesity,
mice were fed a high-fat diet (HFD), containing 45 kcal% fat
(1 cal = 4.184 J). As observed with mice fed the control diet,
Ppp5D274A/D274A gained weight more slowly than Ppp5D274 A/ + and
Ppp5+ / + mice on the HFD (Figure S3B). However, the ratio of
the weight gain of Ppp5D274A/D274A, Ppp5D274 A/ + and Ppp5+ / + mice
after the HFD for 20 weeks to the weight gain after the control
diet for 20 weeks was 2.2, 2.2 and 1.9, respectively, indicating that
Ppp5D274 A/D274A and Ppp5D274 A/ + mice are susceptible to increased
weight gain on a HFD. Indeed glucose tolerance tests (GTT)
showed that after glucose administration, the blood glucose
levels of Ppp5D274A/D274A and Ppp5D274 A/ + mice returned to their
basal levels slightly but significantly more slowly than those
in Ppp5+ / + mice (Figure S3C). No significant differences were
observed between the three Ppp5 mouse genotypes, which all
showed resistance to insulin (data not shown). On termination
of the HFD, the weight ratio of gonadal and omental fat to
liver was higher in Ppp5D274A/D274A and Ppp5D274 A/ + mice than in
control Ppp5+ / + mice (Figure S3D). The studies demonstrate that
inhibition of Ppp5 activity does not protect against HFD-diet-
induced weight gain and fat deposition in mice.
Triacylglycerols (triglycerides) and glucocorticoids were
measured in blood serum. In fasted male mice, triacylglycerols
were significantly lower in Ppp5D274A/D274A compared with
Ppp5+ / + mice (P < 0.001) and Ppp5D274 A/ + mice compared
with Ppp5+ / + controls (P < 0.01), indicating improved lipid
homoeostasis. This is likely to arise because the amounts of
white adipose tissue (WAT) are too low to maintain normal
fasted blood serum triacylglycerol levels. In fed mice, there
were no statistically significant differences, although there was
a trend towards higher levels in the Ppp5D274A/D274A mice compared
with Ppp5+ / + controls, suggesting dietary lipids were not being
stored as rapidly in the Ppp5 mutant mice because of smaller
white fat depots (Figure 4E). The levels of glucocorticoids were
significantly higher in male fasted Ppp5D274A/D274A and Ppp5D274 A/ +
mice than in Ppp5+ / + controls (P < 0.001; P < 0.04), and
in female fasted Ppp5D274A/D274A mice than in Ppp5+ / + controls
(P < 0.03) (Figure 4F), but there were no statistically significant
differences in male or female fed mice (data not shown).
Examination of the phosphorylation state of GR–Hsp90 complexes
in Ppp5+ /+ , Ppp5D274 A/+ and Ppp5D274A/D274A mice
In mice, the major active glucocorticoid is corticosterone,
which binds to and activates GR complexes to modulate the
expression of many genes. If GR function is impaired in
Ppp5 mutant mice, it is envisaged that this may enhance not
only the conversion of the inactive 11-dehydrocorticosterone
into corticosterone but also glucocorticoid release into the
blood plasma from the adrenal. The elevated levels of serum
glucorticoids in Ppp5D274A/D274A mice therefore suggested that
GR function may be impaired in Ppp5 mutant mice and raised
the possibility that GR phosphorylation state may be altered.
The GR protein was difficult to detect in adipose tissue or
MEF lysates and therefore the GR and its phosphorylation
sites for which antibodies are available were examined after
immunoadsorption of the GR in the absence and presence of
the synthetic glucocorticoid, dexamethasone, a high-potency
ligand for GR. Immunoblotting of anti-GR antibody pellets
from MEF lysates shows increased levels of phosphorylation on
GRSer212 and GRSer220 in the mutant mice (sites orthologous
to human GRSer203 and GRSer211, respectively). GRpSer212
was increased in Ppp5D274A/D274A compared with Ppp5+ / + MEFs
in the absence of dexamethasone (Figure 5A). Three different
animals of each genotype were examined and the difference
was statistically significant (P < 0.001). GRpSer220 was also
hyperphosphorylated in Ppp5D274A/D274A compared with Ppp5+ / +
cells in the absence of dexamethasone (Figure 5B). The
similar levels of GRpSer220 in untreated and dexamethasone
treated Ppp5D274A/D274A MEFs are consistent with GRpSer220
being hyperphosphorylated in the absence of dexamethasone.
Quantification by the Li-Cor Odyssey detection system shows
that in the absence of dexamethasone, the GRpSer220/GR
phosphorylation ratio is increased approximately 10-fold in
Ppp5D274A/D274A MEFs compared with the GRpSer220/GR ratio
in Ppp5+ / + MEFs (Figure 5C). Treatment with dexamethasone
increases the GRpSer220/GR ratio 18-fold in Ppp5+ / + MEFs,
whereas there is a 5-fold increase in Ppp5D274 A/ + MEFs and
only a marginal increase in Ppp5D274A/D274A MEFs compared with
the levels in untreated MEFs (Figure 5C). The reason for lower
GRp220/GR ratios in Ppp5D274A/D274A and Ppp5D274 A/ + compared
with Ppp5+ / + MEFs in the presence of dexamethasone is unclear,
but could be due to the degradation of GRpSer220 when it cannot
be dephosphorylated.
As expected Hsp90 and Ppp5 are present in GR immunopellets
from preadipocyte lysates (Figure 5D) and MEF lysates.
Following electrophoretic separation of the proteins in GR
immunopellets from MEF lysates (data not shown), analysis by
mass spectrometry identified Hsp90AB (orthologous to human
Hsp90β) as the only Hsp90 isoform in the GR from both
Ppp5+ / + and Ppp5D274A/D274A MEFs. The Hsp90 co-chaperone
Cdc37, phosphorylated in vivo on Ser13, is reported to be
dephosphorylated by Ppp5 [21]. However, we did not observe
a significant difference in the phosphorylation state of Cdc37 at
Ser13 in Ppp5D274A/D274A, Ppp5D274 A/ + and Ppp5+ / + in MEF lysates
(data not shown). PPARγ (peroxisome proliferator-activated
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Figure 4 Differentiation of preadipocytes from Ppp5+ /+ , Ppp5D274 A/+ and Ppp5D274A/D274A mice and blood serum glucose, triacylglycerol and glucocorticoid
levels
(A) Preadipocytes isolated from gonadal fat were cultured for 10 days in RPMI medium containing complete FBS (with one passage), fixed in p-formaldehyde and initially viewed using differential
interference contrast (DIC). DNA was stained with DAPI (blue), fat droplets with Nile Red and the merged images are shown on the right for all three genotypes as indicated. (B, C) Two hundred cells
were scored for DAPI staining (preadipocyte total) and Nile Red (presence of fat droplets) in cultures grown in (B) RPMI medium (with complete FBS) (C) RPMI medium (with dialysed FBS, molecules
<10 kDa removed). The presence of differentiated adipocytes indicated by fat droplets was significantly higher in Ppp5+ / + cultures than in Ppp5D274 A/ + and Ppp5D274A/D274A cultures. Preadipocytes
cultured from three mice of each genotype showed similar results. Error bars indicate the SEM and statistical significance by *P < 0.01, **P < 0.005, ***P < 0.0005. (D) Glucose tolerance test on
33–41-week-old male mice fed ad libitum on a standard chow diet and fasted (12 h) prior to the tests (8 Ppp5D274A/D274A, 9 Ppp5D274 A/ + , 12 Ppp5+ / + mice). Ppp5D274A/D274A mice showed a small
increase in glucose tolerance compared with Ppp5+ / + mice, which was statistically significant at the 30 min, 120 min (*P < 0.05) and 60 min (**P < 0.01) time points post glucose injection. (E)
Serum triacylglycerol (triglyceride) and (F) glucocorticoids were measured in blood serum from three male or three female, fed or fasted for 6 h Ppp5D274A/D274A, Ppp5D274 A/ + and Ppp5+ / + mice
between 3.5 and 8 months old (but age-matched for genotypes). The blood serum triacylglycerol levels were decreased in fasted male Ppp5D274A/D274A compared with Ppp5+ / + mice ***P < 0.001
and Ppp5D274 A/ + compared with Ppp5+ / + mice **P < 0.01. The glucocorticoid level was significantly higher in male fasted Ppp5D274A/D274A mice than in Ppp5+ / + controls ***P < 0.001, female
fasted Ppp5D274A/D274A mice than in Ppp5+ / + controls **P < 0.03 and in male fasted Ppp5D274 A/ + mice than in Ppp5+ / + controls *P < 0.04. Serum glucocorticoid levels in fed male and female
mice was below 0.8 ng/ml.
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Figure 5 Analysis of GR complexes in MEFs and preadipocytes and PPARγ complexes in adipose tissue from Ppp5+ /+ , Ppp5D274 A/+ and Ppp5D274A/D274A mice
(A) MEFs were cultured in DMEM and dialysed FBS. GR complexes were immunoadsorbed from Ppp5+ / + and Ppp5D274A/D274A MEF lysates and immunoblotted for the GR and GRpSer212
(orthologous to human GRpSer203). Marker protein sizes on the left in kDa. A representative blot of three independent experiments is shown. Below, the data were averaged from the three blots. Error
bars indicate the SEM and the difference is statistically significant (P < 0.001). (B) MEFs were cultured in DMEM and dialysed FBS with and without 500 nM dexamethasone (Dex) for 4 h. The GR
was immunoadsorbed and blotted for the GR and GRpSer220 (orthologous to human GRpSer211). Ppp5 in the GR complexes is shown. IgG replacing the anti-GR employed for immunoadsorption
served as a control for non-specific adsorption. GAPDH and the GR present in the lysate prior to immunoadsorption are controls. M, marker proteins in kDa. (C) Quantification of the data from (B)
showing GR Ser220 is hyperphosphoryled in Ppp5D274 A/ + and Ppp5D274A/D274A MEFs compared with Ppp5+ / + MEFs from the untreated cultures, but not in dexamethasone treated cells. Error bars
relate to Li-Cor Odyssey quantifications. Similar hyperphosphorylation of GR Ser220 was noted in three independent experiments. (D) Preadipocytes were cultured in DMEM and dialysed FBS.
The GR complexes were immunoadsorbed from the lysates and the proteins identified in the pellets by immunoblotting are indicated. The HEK293 lysate facilitates identification of the preadipocyte
proteins. M, marker proteins in kDa. (E) PPARγ complexes were immunoadsorbed from the preadipocyte lysates and the proteins identified in the pellets by immunoblotting are indicated. IgG
replacing the anti-PPARγ employed for immunoadsorption served as a control for non-specific adsorption. (F) Lysates from gonadal fat pads are examined by immunoblotting with antibodies to the
indicated proteins.
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receptor-γ ) plays a key role in lipid accumulation [22] and binds
to Hsp90 and Ppp5 in preadipocyte lysates (Figure 5E). PPARγ is
reported to be regulated by dephosphorylation of phosphoSer112
by Ppp5 [23]. However, there was no significant difference in
the phosphorylation of PPARγ Ser112 (orthologous to human
Ser 114) in gonadal adipose tissue lysates from Ppp5D274A/D274A,
Ppp5D274A/D274A and Ppp5+ / + mice (Figure 5F).
The GR has been shown to bind and inhibit mothers against
decapentaplegic homologue 3 (SMAD3), which is an intracellular
signal transducer relaying the transforming growth factor (TGF)-
β signal to the nucleus from the TGF-β receptor kinase
in the cell membrane [24]. The GR immunoadsorbed from
preadipocyte lysates of gonadal fat pads of Ppp5+ / + Ppp5D274 A/ +
and Ppp5D274A/D274A mice interacted with the same amounts of
SMAD3 and SMAD3 phosphorylated on Ser243 and Ser245
(data not shown). PPARγ immunoadsorbed from the preadipocyte
lysates was also observed to bind SMAD3 (Figure 5E). However,
the SMAD3 bound to PPARγ , and the levels present in gonadal
adipose tissue lysates (Figure 5F) were the same in Ppp5+ / +
Ppp5D274 A/ + and Ppp5D274A/D274A mice.
Investigation of proteins regulating preadipocyte differentiation
Glucocorticoids have been shown to play a major role in
differentiation of preadipocytes to adipocytes by decreasing
transcription of the mRNA encoding Delta-like protein-1
(DLK1)/Preadipocyte factor-1 (Pref-1)/foetal antigen-1(FA1), in
the early stages of preadipocyte differentiation [25,26]. In order
to examine the effect of an inactive Ppp5 on this pathway, DLK1
and other proteins identified in the regulation of adipogenesis were
investigated in predipocytes isolated from gonadal adipose tissue
of mice expressing active and inactive Ppp5. Immunoblotting
of lysates of preadipocytes, isolated from gonadal fat pads and
cultured in vitro for 9 days showed that DLK1 was increased
in level in Ppp5D274 A/ + and Ppp5D274A/D274A cells compared with
Ppp5+ / + cells, indicating that transcription of DLK1 mRNA
was not being repressed by the GR when Ppp5 was inactivated
(Figures 6A and 6B). From studies in Pref1/DLK1 null mice,
DLK1 was shown to induce expression of the transcription factor
(sex determining region Y)-box 9 (SOX9) through activation
of the extra-cellular signal regulated kinase (ERK)/mitogen-
activated protein kinases (MAPK) pathway, leading to inhibition
of forced adipocyte differentiation in MEFs, by repression of
CCAAT enhancer binding protein-β (C/EBPβ) and C/EBPδ
[27,28]. In Ppp5D274 A/ + and Ppp5D274A/D274A preadipocyte cultures,
the concentration of SOX9 was increased compared with that
in Ppp5+ / + preadipocyte cultures, whereas the glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) control did not vary
(Figures 6A and 6B). Phosphorylated ERK2 was increased
in Ppp5D274A/D274A compared with Ppp5+ / + preadipocytes. The
concentration of C/EBPβ, and that of C/EBPα which regulates
terminal adipocyte differentiation [29,30], were decreased
in Ppp5D274 A/ + and Ppp5D274A/D274A compared with Ppp5+ / +
preadipocyte lysates. C/EBPδ and PPARγ were below the level
of detection in preadipocyte lysates.
The concentrations of fatty acid binding protein 4 (FABP4)
involved in the uptake and transport of fatty acids, fatty
acid synthase (FAS) and phosphoenolpyruvate carboxykinase
(PEPCK/PCK), a regulator of gluconeogenesis, were similar
in preadipocyte lysates from Ppp5+ / + Ppp5D274 A/ + and
Ppp5D274A/D274A mice (Figure 6C). The concentration of the
glucose transporter (GLUT4) was sometimes slightly increased
in Ppp5D274 A/ + and Ppp5D274A/D274A compared with Ppp5+ / +
preadipocytes (data not shown) but also observed at similar levels
in other preadipocyte cultures of all three genotypes (Figure
6C). Other proteins relevant to lipid metabolism were examined
in the adipose tissue surrounding the gonads. No changes in
expression levels of 11-β-hydroxysteroid dehydrogenase (11-β-
HSD1), adiponectin and perilipin were observed (Figure 6D).
Visual examination of tissues did not suggest that lipid levels
were increased in Ppp5D274A/D274A to compensate for the decreased
lipid stored in white gonadal and peri-renal adipose tissue. In
addition, measurement of lipids in the liver showed no significant
difference between the livers of three paired Ppp5D274A/D274A and
Ppp5+ / + mice (Average 8.5 v 8.3% lipid/g respectively with
5% difference between each pair of mice).
As the lower body mass of Ppp5D274A/D274A compared with
Ppp5+ / + cannot simply be explained by decreased adipogenesis
but necessitates some change in energy intake or expenditure, tests
were undertaken to address this point. However, no statistically
significant difference in standard chow intake was observed
between four Ppp5D274A/D274A, three Ppp5D274 A/ + and three Ppp5+ / +
12-week-old female mice when food was weighed every 2 days
over 2 weeks [average (g) 50.5 +− 0.4, 52.2 +− 1.1, 54.0 +− 3.0,
respectively]. The high level of glucocorticoids in the blood
suggested the possibility that the expression of UCP1 (uncoupling
protein-1) may be modified in Ppp5D274A/D274A mice resulting in loss
of energy through heat generation [31], but analyses showed no
increase of expression in UCP1 in brown adipose tissue (BAT)
and no UCP1 expression in white gonadal tissue from three
Ppp5D274A/D274A mice, which would suggest the presence brite/beige
adipose tissue or adipocytes in this fat depot of Ppp5D274A/D274A mice
(Figure 6E).
DISCUSSION
The mouse model we have engineered here, in which the wild-
type Ppp5 gene is replaced by a gene expressing a Ppp5 protein
with severely deficient activity, exhibits a major phenotype of
decreased adipose tissue surrounding gonads and kidneys, and
a reduction in size of the adipocytes present. The decrease in
adipose tissue, evident by weighing, correlated well with data
obtained by MRI. Our biochemical analyses, including elevated
serum glucorticoids, suggest that the primary defect underlying
this phenotype may be an alteration in GR function during the
early stages of adipose tissue differentiation from preadipocytes.
We demonstrate that preadipocytes expressing inactivated Ppp5
differentiate more slowly in culture than in wild-type preadipo-
cytes and that more stromal cells, which include preadipocytes, are
present in the gonadal fat pads of Ppp5D274A/D274A mice, data which
support a block in an early step of preadipocyte differentiation.
Two mouse PP5KO models were previously analysed without not-
ing decreased amounts of adipose tissue or biochemical alterations
in this tissue [17,18]. Our studies on the Ppp5D274 A ‘knockin’ (KI)
(Ppp5KI) mouse are the first to report the effects of inactivated
Ppp5 on GR phosphorylation and differentiation in adipose tissue
of an animal model. Homozygous Ppp5KI and PP5KO mice were
viable and fertile, but selection against the homozygous male
offspring of Ppp5KI heterozygous intercrosses was statistically
significant and a similar prenatal effect was observed in one of
the KO models [18]. Our genetic analyses further show that there
is a trend towards significance for selection against homozygous
Ppp5KI female offspring and 13.5-day male/female embryos of
Ppp5D274 A/ + intercrosses. These analyses indicate a major role for
Ppp5 before birth and are consistent with modulation of the GR,
which is essential for early development [32].
Three conserved serine residues are known to be
phosphorylated within the N-terminal region of the GR and
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Figure 6 Investigation of proteins regulating preadipocyte differentiation and other processes in gonadal adipose tissue
(A–C) Lysates of preadipocytes cultured in DMEM and dialysed FBS. (A) Immunoblotting of proteins regulating adipogenesis. Lysates of human 3T3L1 cells facilitate identification of the mouse
preadipocyte proteins. The concentrations of DLK1 and SOX9 are increased in Ppp5D274 A/ + and Ppp5D274A/D274A compared with Ppp5+ / + cell lysates. ERK2 phosphorylation on Thr182 and Tyr184
is increased in Ppp5D274A/D274A compared with Ppp5+ / + lysates. CEBPβ and CEBPα are decreased in Ppp5D274 A/ + and Ppp5D274A/D274A compared with Ppp5+ / + lysates. GAPDH from the same
mouse lysates serves as a control for equal loading of the samples. The position of the marker proteins in kDa is shown on the left. Representative blots of independent experiments are shown. (B)
Quantification of immunoblotting data in (A) with respect to the concentration of GAPDH. The results are averaged from three independent experiments employing preadipocyte cultures from different
mice for each genotype, *P < 0.02, **P < 0.005, ***P < 0.001, ****P < 10− 6. (C) Immunoblotting of preadipocyte lysates for proteins regulating glucose and fatty acid metabolism. GAPDH
from the same mouse lysates serves as a control for equal loading of the samples. HEK293 lysate facilitates identification of the preadipocyte proteins. Marker proteins in kDa are indicated on the
left. (D) Lysates of gonadal adipose tissue lysate were immunoblotted for the indicated proteins. M, marker proteins in kDa. (E) Immunoblotting of lysates from interscapular brown adipose tissue
(BAT) and white gonadal tissue (WAT) for UCP1. The UCP1 protein band was blocked by a specific blocking peptide (data not shown). The GAPDH control for loading was detected on the same blot
subsequent to UCP1 detection and at a different wavelength by Li-Cor Odyssey software. Maximum loading (50 μg protein) was carried out to determine whether UCP1 is present in Ppp5D274A/D274A
WAT. The tissues were from five different mice as indicated.
important for the transcriptional regulation in human cells
(Ser203, Ser211 and Ser226) [33] and in murine cells
(Ser212, Ser220 and Ser234, respectively) [34]. In our studies,
the GR was hyperphosphorylated at Ser212 and Ser220 in
Ppp5D274A/D274A MEFs compared with Ppp5+ / + controls, when
the MEFs were cultured in DMEM containing dialysed FBS,
to remove glucocorticoids. No clear changes were observed
in phosphorylation of Ser234, which was difficult to detect
(data not shown). Studies in human osteosarcoma cell line
U2OS stably expressing human GR and depleted of Ppp5 by
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Figure 7 Model comparing the roles of Ppp5 in GR function during initiation of preadipocyte differentiation in Ppp5+ /+ and Ppp5D274A/D274A mice
Preadipocyte differentiation is inhibited via a 50 kDa factor cleaved from membrane tethered DLK/Pref1, which binds to a receptor leading to phosphorylation and activation of the ERK/MAPK pathway
in the cell cytoplasm and SOX9 in the nucleus, blocking the transcription of CEBPβ and CEBPδ (CEBPβ/δ) [36]. In wild-type Ppp5+ / + mice, glucocorticoids bind to the GR and Hsp90-Ppp5
is probably replaced by Hsp90-FKBP51 (not shown). Loss of Ppp5 enhances phosphorylation of GRSer212 and GRSer220, and the liganded, phosphorylated GR is imported into the nucleus,
where it binds to the promoter of the DLK1 gene, leading to down regulation of DLK1 and initiation of preadipocyte differentiation. CEBP is induced as the levels of CEBPβ and CEBPδ decline,
which contributes to the induction of PPARγ necessary for the accumulation of lipid. In Ppp5D274A/D274A mice, the GR is maximally hyperphosphorylated on Ser212 and Ser220 in the absence
and presence of interaction with glucocorticoids. The inactive Ppp5 may stay bound to the GR through Hsp90. Hyperphosphorylated GR may not interact optimally with glucocorticoids and some
may remain in the unliganded (glucocorticoid free) form, which may not function and/or may block the GR down regulation of DLK1 and thus initiation of adipogenesis. SMAD3 interactions
shown do not differ in Ppp5D274A/D274A and Ppp5+ / + preadipocytes. Decreasing the glucocorticoid level in preadipocyte cultures (Figure 4C compared with Figure 4B) may increase the unliganded
hyper-phoshorylated form of GR in Ppp5D274A/D274A preadipocytes, further decreasing the GR regulated down regulation of DLK1 and adipogenesis. In Ppp5+ / + preadipocytes, active Ppp5 keeps
unliganded GR dephosphorylated allowing the low levels of glucocorticoid bound GR to inhibit the down-regulation of DLK1 in a few preadipocytes and allow adipogenesis.
siRNA, reported hyperphosphorylation of human GR Ser203 and
Ser226 but not Ser211 [16]. It is possible that the use of the
osteosarcoma cell line or culture in the presence of complete
FBS (which probably contains glucocorticoids) may account for
the differences observed at human Ser211 (mouse Ser220) and
human Ser226 (mouse Ser234). Addition of dexamethasone to
the MEFs in our studies led to hyperphosphorylation of the GR at
Ser212 and Ser220 in all three Ppp5 genotypes. Our data therefore
suggest that the main role of Ppp5 in regulating the GR is when
the GR is in the unliganded state.
The GR interacts with the chaperone Hsp90, which binds the
Ppp5 TPR domain via its TPR acceptor site [11,35]. Our studies
show that in Ppp5+ / + control mice the quantity of Ppp5, which is
bound to the GR–Hsp90 complex, decreases when dexamethasone
is bound to the GR (Figure 5B), suggesting the role of Ppp5 may be
to keep the GR dephosphorylated in the unliganded form (Figure
7). In the Ppp5D274 A/ + and Ppp5D274A/D274A MEFs, where Ppp5 is
at least partially inactive, the quantity of Ppp5 bound is more
variable.
Although there was a severe decrease in the size of the gonadal
and kidney fat pads in Ppp5D274A/D274A mice, preadipocytes could be
isolated from these tissues, but after 8–10 days in RPMI medium
and FBS, differentiation of the preadipocytes to adipocytes was
retarded in Ppp5D274A/D274A and Ppp5D274 A/ + cultures compared
with Ppp5+ / + cultures, pointing to a major defect in preadipocyte
differentiation in Ppp5 deficient mice. Previous studies examined
PP5KO MEFs cultured in a medium to force conversion into
adipocytes [DMEM, 10% FBS, 1 μM dexamethasone, 830 nM
insulin, 100 μM isobutylmethylxanthine, 5 μM rosiglitazone
(an agonist of PPARγ )] [23]. The authors observed that the
abundance of cells with lipid accumulation was lower in PP5KO
compared with the PP5WT (wild-type) cells. However, the GR
was reported to be hyperphosphorylated in PP5KO MEFs when
activated by dexamethasone and the PPARγ 2 (transfected into the
MEFs) hyperphosphorylated on Ser112 with inactivation. The
abrogation of PPARγ activity was described as the dominant
mechanism preventing lipid accumulation in PP5KO MEFs. This
contrasts with our study, which shows clear differences in GR
phosphorylation in the unliganded form in MEFs and no changes
in endogenous PPARγ Ser112 phosphorylation in gonadal fat
pads.
The transmembrane protein DLK1/Pref1/FA1, with six EGF
(epidermal growth factor)-like repeats on the extracellular
domain, has been recognized as a crucial factor in the
differentiation of preadipocytes to mature adipocytes [36].
Tumour necrosis factor-α (TNF-α) converting enzyme (TACE)
is reported to cleave DLK1, generating a 50 kDa soluble
extracellular form, which interacts with fibronectin and the cell
membrane protein integrin α5β1, leading to activation of an
ERK/MAPK, SOX9 pathway to block CEBPβ/δ transcription
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and adipocyte differentiation. Dexamethasone was shown to
decrease DLK1 expression, allowing an increase of CEBPβ/δ and
adipocyte differentiation [25]. Our studies show that after culture
of preadipocytes in RPMI medium and dialysed FBS (to remove
glucocorticoids), DLK1 and SOX9 protein concentrations are
higher in Ppp5D274 A/ + and Ppp5D274A/D274A than in Ppp5+ / + cultures,
resulting in lower expression levels of the CEBPβ. CEBPα,
which is induced by CEBPβ, therefore exhibits lower expression
levels. No comparable studies on the proteins regulating the
pathways of adipogenesis were performed in mouse PP5KO
models [17,18,23].
As the major phenotype of Ppp5D274A/D274A mice was observed
in adipose tissue, several proteins were examined in gonadal
fat pad or preadipocyte lysates. However, we observed no
difference in the concentration of 11-β-HSD1, which converts
the inactive 11-dehydrocorticosterone (cortisone in humans) into
active corticosterone (cortisol in humans) [37]. There was also no
alteration in adiponectin, involved in the modulation of lipid and
glucose metabolism in insulin sensitive tissues [38], PEPCK a
major regulator in gluconeogenesis, dependent on binding of the
GR to DNA for induction [39], FABP4 [40] and perilipin, [41],
which mediate transport and release of fatty acids, respectively.
The concentration of FAS, a rate-limiting enzyme of fatty acid
synthesis, was also similar in Ppp5D274A/D274A, Ppp5D274 A/ + and
Ppp5+ / + mice. The more variable levels of GLUT4, which were
sometimes, but not always, raised in Ppp5D274A/D274A preadipocytes,
may be a compensatory response to low lipid levels and account
for the slightly increased insulin sensitivity of the mice in
Ppp5D274A/D274A preadipocytes. The decreased lipid in gonadal and
peri-renal fat pads raised the possibility that dietary fat was being
stored in other tissues, but the hepatic lipid levels of Ppp5D274A/D274A
mice were not elevated, providing no evidence for excess fat
deposition in this tissue.
Our studies show an interaction of SMAD3 with GR–Hsp90–
Ppp5 complexes consistent with previous studies using cell
lines, which also showed that the transcriptional activation
function of SMAD3 was inhibited by a mechanism dependent
on interaction with the GR [24]. Molecular modelling has
suggested that phosphorylation of the GR at Ser211 promotes
a conformational change, which may enhance interaction with
certain proteins [42], but we found no evidence for differences in
SMAD3 binding to the GR in preadipocytes from Ppp5D274A/D274A,
Ppp5D274 A/ + and Ppp5+ / + mice, although the levels of GRpSer212
and GRpSer220 differed in the three genotypes. We observed
that SMAD3 also interacted with PPARγ –Hsp90 complexes
in preadipocytes. SMAD3 has been shown to interact with
CEBPβ/CEBPδ complexes with inhibition of their transcriptional
activity [43,44]. A weak interaction of SMAD3 with PPARγ
was also observed in these studies, but no evidence for PPARγ
inhibition. Therefore, although our data point to an additional
role of Ppp5 in PPARγ function, we have no evidence that
interactions with SMAD3 are different in Ppp5+ / + , Ppp5D274 A/ +
and Ppp5D274A/D274A mice. Our data show that Ppp5 plays a
key role in keeping the unliganded (glucocorticoid-free) GR
dephosphorylated at Ser212 and Ser220, which appears to be
essential for GR-mediated repression of DLK1, a process required
for the initiation of differentiation in proliferating preadipocytes.
Other recent studies have provided evidence that the unliganded
form of the GR may be crucial for some GR functions [45,46].
The decreased body mass of the Ppp5D274A/D274A mice compared
with Ppp5+ / + mice cannot be explained solely by a GR-mediated
decrease in adipogenesis, but necessitates a change in energy
balance. An examination of food intake and the generation of
heat through the expression levels of UCP1 in interscapular BAT
uncovered no differences between Ppp5D274A/D274A and Ppp5+ / +
mice. There has been much recent interest in brite or beige
adipocytes developing in WAT, as they may play an important
role in mice losing weight through elevation of UCP1, which can
occur following cold or β-adrenergic stimulation [47]. However,
we found no evidence for the existence of UCP1 in gonadal WAT
of several Ppp5D274A/D274A mice. Therefore, at the present time it is
unclear how the energy intake and expenditure are balanced, but
glucocorticoids have wide ranging metabolic effects which may
individually be hard to detect.
Ppp5D274A/D274A mice exhibited slightly improved GTT and
insulin sensitivity compared with Ppp5+ / + mice on a standard
control diet. During the course of our studies, it was reported
that PP5KO mice showed improved GTT but no increase in
insulin sensitivity [48]. Recent studies from the same group report
that PP5KO mice fed a control diet exhibit decreased kidney,
epididymal and subcutaneous fat depots [49], consistent with our
analyses of Ppp5KI mice by weighing and MRI of kidney and
gonadal fat depots. Feeding a HFD (45%) for 20 weeks increased
weight gain, lowered GTT and led to insulin resistance in Ppp5KI
mice and controls. In contrast, PP5KO mice fed a HFD (60%)
for 10 weeks, gained less weight and maintained improved GTT
compared with control mice after the same HFD. The differences
may arise from the different length and composition of the HFDs
or possibly the use of Cre/loxP technology to generate the PP5KO
mice [18], which has been questioned recently in relation to
metabolic phenotypes [50]. In addition, deletion of Ppp5 protein
in KO mice may allow a different phosphatase to partially or
fully substitute for Ppp5. There can be a problem in interpreting
results from KO mice, in which both regulatory and catalytic
domains are deleted. Analysing a KI model, like Ppp5D274 A, in
which a single functional domain of the protein is disabled, may
lead to better prediction of the consequences that could arise from
administration of an inhibitor of catalytic function.
Overall our data provide clear evidence that inactivation
of Ppp5 in vivo in the presence of normal or 2-fold
elevation of blood serum glucocorticoid levels partially inhibits
preadipocyte differentiation and that Ppp5D274A/D274A mice on
a standard diet show increased insulin sensitivity. Initial
studies (Doron Rosenzweig, Wright Jacob and Patricia T.W.
Cohen – unpublished) have not uncovered significant altered
immunological responses in macrophages from Ppp5D274A/D274A
compared with Ppp5+ / + mice. Therefore, although inhibition of
Ppp5 is unlikely to decrease existing visceral obesity, decreasing
Ppp5 activity may be beneficial to prevent obesity during
glucocorticoid treatment, if inhibition of other reported roles of
Ppp5 is not detrimental.
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